What Happened
Dr. Pranathi V. Reddy, a dentist in Bucks County, Pennsylvania, agreed to pay $150,000 and to stop prescribing Schedule II opioids for four years to resolve allegations that she diverted controlled substances from her own practice for personal use.
The settlement resolved allegations that on October 14, 2018, Reddy diverted a package of controlled substances for personal use, an episode that resulted in an overdose and her own transport to a hospital. Investigators also found that from June 2017 through November 2018, Reddy failed to maintain the recordkeeping required of a DEA registrant handling controlled substances — including an initial controlled-substance inventory, transfer documentation, and proof that the drugs were kept at her registered practice location.
Under the civil settlement with the U.S. Attorney's Office, announced December 31, 2019, Reddy is barred from purchasing, prescribing, or dispensing any Schedule II controlled substance for at least four years and must report her controlled-substance purchasing, dispensing, and prescribing activity to the DEA. The settlement resolved allegations only, with no admission of liability.
What Went Wrong
- No safeguard caught a prescriber diverting from her own supply. A solo practitioner with DEA registration privileges had unsupervised access to the controlled substances stocked in her own office.
- Basic recordkeeping wasn't in place. The practice lacked an initial controlled-substance inventory and documentation of transfers, obligations required of every DEA registrant regardless of practice size.
- An overdose was the trigger, not a routine audit. The diversion only came to light after Reddy herself overdosed and was hospitalized — there was no earlier detection mechanism.
How It Could Have Been Prevented
- Maintain a complete initial inventory and ongoing transfer records for all Schedule II–V substances, even in a single-provider practice.
- Store controlled substances only at the registered location and reconcile physical counts against records on a fixed schedule.
- Build in a peer-review or third-party audit mechanism for solo practices that lack the internal checks a hospital or health system pharmacy would normally provide.
- Treat any prescriber impairment or unexplained absence as a potential red flag warranting an immediate controlled-substance reconciliation.
Related Guidance
- Regulatory Guide — DEA registrant recordkeeping and inventory requirements under the Controlled Substances Act.
- 15 Red Flags of Drug Diversion — Indicators of self-diversion by licensed prescribers.
- Community Pharmacy & Practice Self-Assessment Checklist — Self-assessment for small and solo healthcare practices.
- Diversion Case Registry — Related cases involving individual prescriber diversion.